AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec. AstraZeneca in a statement said ...

Oct. 3 (UPI) --Multinational pharmaceutical maker AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company's heartburn ...

AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA approval for the ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...

AstraZeneca was sued on Aug. 26 in Pennsylvania Eastern District Court over alleged employment discrimination. The court case was brought by the Gold Law Firm on behalf of a former senior user ...

The settlement will resolve all pending US lawsuits over Xarelto ... Women with HER2-positive breast cancer can be treated with AstraZeneca and Daiichi Sankyo's Enhertu, regardless of whether ...

The 2024 State Scorecard on Women's Health and Reproductive Care was conducted by the Commonwealth Fund, a nonpartisan foundation that promotes a high-performing health care system. (Barbor, 9/16) CBS ...

Let’s take a look at the history of illegal and fraudulent dealings by players in the pharmaceutical industry; an industry that has way more power and influence than we give them credit for.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...